108 related articles for article (PubMed ID: 2414239)
1. Immunohistochemical study of amylase in common epithelial tumors of the ovary.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Abe Y; Ogawa M
Int J Gynecol Pathol; 1985; 4(3):240-4. PubMed ID: 2414239
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of amylase in endometrial carcinomas.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Nishino T; Ogawa M
Int J Gynecol Pathol; 1986; 5(1):47-51. PubMed ID: 2420737
[TBL] [Abstract][Full Text] [Related]
3. Amylase in fallopian tube and serous ovarian neoplasms: immunohistochemical localization.
Bruns DE; Mills SE; Savory J
Arch Pathol Lab Med; 1982 Jan; 106(1):17-20. PubMed ID: 6172088
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of amylase in endometrioid carcinomas of the ovary.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Nishino T; Saito J; Abe Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):149-50. PubMed ID: 2579172
[No Abstract] [Full Text] [Related]
5. Hyperamylasemia associated with endometrioid carcinoma of the ovary: case report and immunohistochemical study.
Yagi C; Miyata J; Hanai J; Ogawa M; Ueda G
Gynecol Oncol; 1986 Oct; 25(2):250-5. PubMed ID: 2428702
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical localization of estradiol in malignant epithelial tumors of the ovary].
Takamizawa M; Yaoi Y; Kumasaka T; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):359-66. PubMed ID: 3559322
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
Bell KA; Kurman RJ
Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848
[TBL] [Abstract][Full Text] [Related]
8. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
9. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB
Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888
[TBL] [Abstract][Full Text] [Related]
10. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
12. Serous ovarian neoplastic amylase (SONA): a potentially useful marker for serous ovarian tumors.
Van Kley H; Cramer S; Bruns DE
Cancer; 1981 Sep; 48(6):1444-9. PubMed ID: 6168366
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
14. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary.
Georgakopoulos P; Mehmood S; Akalin A; Shroyer KR
Int J Gynecol Pathol; 2012 Nov; 31(6):517-23. PubMed ID: 23018214
[TBL] [Abstract][Full Text] [Related]
16. Human ovarian tumors express gamma-glutamyl transpeptidase.
Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
[TBL] [Abstract][Full Text] [Related]
17. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
[TBL] [Abstract][Full Text] [Related]
19. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary.
Norris HJ
Int J Gynecol Pathol; 1993 Apr; 12(2):134-40. PubMed ID: 8463037
[TBL] [Abstract][Full Text] [Related]
20. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
